Robert Pearl

For 18 years, Robert Pearl, MD served as CEO of The Permanente Medical Group (Kaiser Permanente). He is also former president of The Mid-Atlantic Permanente Medical Group. In these roles, he led 10,000 physicians, 38,000 staff and was responsible for the nationally recognized medical care of 5 million Kaiser Permanente members on the west and east coasts.

He is a clinical professor of plastic surgery at Stanford University School of Medicine and on the faculty at the Stanford Graduate School of Business, where he teaches courses on healthcare strategy, technology, and leadership. Pearl is board certified in plastic and reconstructive surgery, receiving his medical degree from Yale, followed by a residency in plastic and reconstructive surgery at Stanford University.

He’s the author of three books: "Mistreated: Why We Think We’re Getting Good Healthcare—And Why We’re Usually Wrong," a Washington Post bestseller (2017); "Uncaring: How the Culture of Medicine Kills Doctors & Patients," a Kirkus star recipient (2021); and his newest book "ChatGPT, MD: How AI-Empowered Patients & Doctors Can Take Back Control of American Medicine" (April 2024). All profits from sales of his books go to Doctors Without Borders.

Dr. Pearl is a LinkedIn “Top Voice” in healthcare and host of the popular podcasts "Fixing Healthcare" and "Medicine: The Truth." He publishes two monthly healthcare newsletters reaching 50,000+ combined subscribers. A frequent keynote speaker, Pearl has presented at The World Healthcare Congress, the Commonwealth Club, TEDx, HLTH, NCQA Quality Talks, the National Primary Care Transformation Summit, American Society of Plastic Surgeons, and international conferences in Brazil, Australia, India, and beyond.

Pearl’s insights on generative AI in healthcare have been featured in Associated Press, USA Today, MSN, FOX Business, Forbes, Fast Company, WIRED, Global News, Modern Healthcare, Medscape, Medpage Today, AI in Healthcare, Doximity, Becker’s Hospital Review, the Advisory Board, the Journal of AHIMA, and more.